Report Detail
Global (United States, European Union and China) Ebola Treatment Market Research Report 2019-2025
- RnM3650257 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. The harmful consequences of Ebola viral infection are that the viruses can be used as potential biological weapon. The symptoms of Ebola viral infection include sudden onset of fever, sore throat, headaches, extreme tiredness, vomiting, skin rash, muscular pain, etc. Ebola virus causes haemorrhagic fever which may lead to internal or external bleeding. The symptoms appear anywhere from 2 to 21 days after exposure to Ebola, though the average is 8 to 10 days. Diagnostic tests are now being done by ELISA (Antigen-capture enzyme-linked immunosorbent assay), Polymerase Chain Reaction, Virus Location, IgM Elisa and Immunohistochemistry testing. Few vaccines and medical treatments for Ebola are in pipeline and due to the absence of effective treatments, the pharmaceutical companies now have big opportunities in the market globally. As per WHO, several care rehydration methods are adopted with fluid injection orally and other treatments are also taken care of which improves the survival rate. Top drug companies such as Hemispherx Biopharma, Biochryst Pharmaceuticals, Nano Vircides, Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceuticals are among the key players in the global Ebola treatment market and are conducting trials on a set of experimental drugs.
The global Ebola treatment market growth is driven by the increasing incidence rates of Ebola viral infection and Ebola outbreaks. As per WHO, U.S. & U.K. governments, availability of different treatment procedures to treat Ebola is expected to drive the Ebola viral disease market growth during the forecast period. The Ebola treatment market also includes therapies for those who already have Ebola, and vaccines to prevent the deadly virus. Various drug companies and regulators in the U.S. are taking a two-pronged approach in finding a way to treat the virus. Approval of vaccines are taking a longer time but when vaccines undergo trials, adoption and availability could be a limiting factor for global Ebola treatment market growth.
In 2019, the market size of Ebola Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ebola Treatment.
This report studies the global market size of Ebola Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Ebola Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Arbutus Biopharma
GlaxoSmithKline
Johnson & Johnson Services
Hemispherx Biopharma
BioCryst Pharmaceuticals
NanoViricides
NewLink Genetics
Chimerix
Sarepta Therapeutics
Mapp Biopharmaceutical
Market Segment by Product Type
Vaccine (Under Trials)
Drugs (Under Trials)
Market Segment by Application
Hospitals
Ambulatory Surgery Centres
Specialized Clinics
Army Camps (Veteran Facilities)
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Ebola Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Ebola Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Ebola Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Ebola Treatment Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Vaccine (Under Trials)
- 1.3.3 Drugs (Under Trials)
- 1.4 Market Segment by Application
- 1.4.1 Global Ebola Treatment Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Ambulatory Surgery Centres
- 1.4.4 Specialized Clinics
- 1.4.5 Army Camps (Veteran Facilities)
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Ebola Treatment Market Size
- 2.1.1 Global Ebola Treatment Revenue 2014-2025
- 2.1.2 Global Ebola Treatment Sales 2014-2025
- 2.2 Ebola Treatment Growth Rate by Regions
- 2.2.1 Global Ebola Treatment Sales by Regions 2014-2019
- 2.2.2 Global Ebola Treatment Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Ebola Treatment Sales by Manufacturers
- 3.1.1 Ebola Treatment Sales by Manufacturers 2014-2019
- 3.1.2 Ebola Treatment Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Ebola Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Ebola Treatment Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Ebola Treatment Market Concentration Ratio (CR5 and HHI)
- 3.3 Ebola Treatment Price by Manufacturers
- 3.4 Key Manufacturers Ebola Treatment Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Ebola Treatment Market
- 3.6 Key Manufacturers Ebola Treatment Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Vaccine (Under Trials) Sales and Revenue (2014-2019)
- 4.1.2 Drugs (Under Trials) Sales and Revenue (2014-2019)
- 4.2 Global Ebola Treatment Sales Market Share by Type
- 4.3 Global Ebola Treatment Revenue Market Share by Type
- 4.4 Ebola Treatment Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Ebola Treatment Sales by Application
6 United States
- 6.1 United States Ebola Treatment Breakdown Data by Company
- 6.2 United States Ebola Treatment Breakdown Data by Type
- 6.3 United States Ebola Treatment Breakdown Data by Application
7 European Union
- 7.1 European Union Ebola Treatment Breakdown Data by Company
- 7.2 European Union Ebola Treatment Breakdown Data by Type
- 7.3 European Union Ebola Treatment Breakdown Data by Application
8 China
- 8.1 China Ebola Treatment Breakdown Data by Company
- 8.2 China Ebola Treatment Breakdown Data by Type
- 8.3 China Ebola Treatment Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Ebola Treatment Breakdown Data by Company
- 9.2 Rest of World Ebola Treatment Breakdown Data by Type
- 9.3 Rest of World Ebola Treatment Breakdown Data by Application
- 9.4 Rest of World Ebola Treatment Breakdown Data by Countries
- 9.4.1 Rest of World Ebola Treatment Sales by Countries
- 9.4.2 Rest of World Ebola Treatment Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Arbutus Biopharma
- 10.1.1 Arbutus Biopharma Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Ebola Treatment
- 10.1.4 Ebola Treatment Product Introduction
- 10.1.5 Arbutus Biopharma Recent Development
- 10.2 GlaxoSmithKline
- 10.2.1 GlaxoSmithKline Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Ebola Treatment
- 10.2.4 Ebola Treatment Product Introduction
- 10.2.5 GlaxoSmithKline Recent Development
- 10.3 Johnson & Johnson Services
- 10.3.1 Johnson & Johnson Services Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Ebola Treatment
- 10.3.4 Ebola Treatment Product Introduction
- 10.3.5 Johnson & Johnson Services Recent Development
- 10.4 Hemispherx Biopharma
- 10.4.1 Hemispherx Biopharma Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Ebola Treatment
- 10.4.4 Ebola Treatment Product Introduction
- 10.4.5 Hemispherx Biopharma Recent Development
- 10.5 BioCryst Pharmaceuticals
- 10.5.1 BioCryst Pharmaceuticals Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Ebola Treatment
- 10.5.4 Ebola Treatment Product Introduction
- 10.5.5 BioCryst Pharmaceuticals Recent Development
- 10.6 NanoViricides
- 10.6.1 NanoViricides Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Ebola Treatment
- 10.6.4 Ebola Treatment Product Introduction
- 10.6.5 NanoViricides Recent Development
- 10.7 NewLink Genetics
- 10.7.1 NewLink Genetics Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Ebola Treatment
- 10.7.4 Ebola Treatment Product Introduction
- 10.7.5 NewLink Genetics Recent Development
- 10.8 Chimerix
- 10.8.1 Chimerix Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Ebola Treatment
- 10.8.4 Ebola Treatment Product Introduction
- 10.8.5 Chimerix Recent Development
- 10.9 Sarepta Therapeutics
- 10.9.1 Sarepta Therapeutics Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Ebola Treatment
- 10.9.4 Ebola Treatment Product Introduction
- 10.9.5 Sarepta Therapeutics Recent Development
- 10.10 Mapp Biopharmaceutical
- 10.10.1 Mapp Biopharmaceutical Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Ebola Treatment
- 10.10.4 Ebola Treatment Product Introduction
- 10.10.5 Mapp Biopharmaceutical Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Ebola Treatment Sales Channels
- 11.2.2 Ebola Treatment Distributors
- 11.3 Ebola Treatment Customers
12 Market Forecast
- 12.1 Global Ebola Treatment Sales and Revenue Forecast 2019-2025
- 12.2 Global Ebola Treatment Sales Forecast by Type
- 12.3 Global Ebola Treatment Sales Forecast by Application
- 12.4 Ebola Treatment Forecast by Regions
- 12.4.1 Global Ebola Treatment Sales Forecast by Regions 2019-2025
- 12.4.2 Global Ebola Treatment Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Ebola Treatment. Industry analysis & Market Report on Ebola Treatment is a syndicated market report, published as Global (United States, European Union and China) Ebola Treatment Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Ebola Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
